Assyro AI

FDA Orange Book · active-ingredient family

Dextromethorphan hydrobromide; quinidine sulfate

Dextromethorphan hydrobromide; quinidine sulfate is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:NUEDEXTA · NDA 021879

1

Brand (NDA)

3

Generics (ANDA)

1

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
NUEDEXTARLDOTSUKA AMERICA PHARMNDA 021879ABOct 29, 2010

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATESUN PHARMANDA 204196ABJun 03, 2026
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATEHETERO LABS LTD IIIANDA 218426ABAug 28, 2024
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATEACTAVIS ELIZABETHANDA 202934ABOct 10, 2017

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7659282Aug 13, 2026in 2 mo
U-1093

Dextromethorphan hydrobromide; quinidine sulfate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.